Kiltearn Partners LLP Makes New Investment in HCA Healthcare, Inc. $HCA

Kiltearn Partners LLP bought a new position in shares of HCA Healthcare, Inc. (NYSE:HCA) during the second quarter, Holdings Channel reports. The fund bought 37,314 shares of the company’s stock, valued at approximately $14,548,000. HCA Healthcare comprises 3.5% of Kiltearn Partners LLP’s portfolio, making the stock its 9th largest position.

Several other institutional investors have also recently made changes to their positions in HCA. Nomura Asset Management Co. Ltd. lifted its holdings in shares of HCA Healthcare by 6.2% during the 4th quarter. Nomura Asset Management Co. Ltd. now owns 64,237 shares of the company’s stock worth $29,990,000 after acquiring an additional 3,724 shares during the last quarter. Advisors Capital Management LLC boosted its holdings in shares of HCA Healthcare by 61.5% in the 4th quarter. Advisors Capital Management LLC now owns 6,836 shares of the company’s stock worth $3,192,000 after purchasing an additional 2,604 shares in the last quarter. Liberty Wealth Management LLC purchased a new position in shares of HCA Healthcare during the 4th quarter valued at about $1,905,000. Arrowstreet Capital Limited Partnership boosted its stake in HCA Healthcare by 11.9% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 2,311,112 shares of the company’s stock worth $1,078,966,000 after buying an additional 245,887 shares in the last quarter. Finally, Sunbelt Securities Inc. raised its stake in shares of HCA Healthcare by 171.7% during the first quarter. Sunbelt Securities Inc. now owns 6,242 shares of the company’s stock worth $2,954,000 after acquiring an additional 3,945 shares in the last quarter. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Stock Performance

NYSE HCA opened at $429.08 on Friday. HCA Healthcare, Inc. has a fifty-two week low of $353.99 and a fifty-two week high of $556.52. The stock has a market cap of $92.90 billion, a P/E ratio of 14.36, a price-to-earnings-growth ratio of 1.49 and a beta of 1.10. The stock has a 50 day simple moving average of $397.16 and a two-hundred day simple moving average of $444.14.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Friday, July 24th. The company reported $7.59 EPS for the quarter, beating analysts’ consensus estimates of $7.56 by $0.03. The company had revenue of $20.23 billion during the quarter, compared to the consensus estimate of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The firm’s revenue for the quarter was up 8.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $6.84 earnings per share. Sell-side analysts predict that HCA Healthcare, Inc. will post 29.47 earnings per share for the current year.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th will be paid a dividend of $0.78 per share. The ex-dividend date of this dividend is Wednesday, September 16th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.7%. HCA Healthcare’s payout ratio is presently 10.45%.

Analyst Ratings Changes

Several analysts have issued reports on the stock. Mizuho cut their price target on shares of HCA Healthcare from $525.00 to $475.00 and set an “outperform” rating for the company in a research report on Tuesday, July 28th. Truist Financial dropped their target price on HCA Healthcare from $535.00 to $495.00 and set a “buy” rating for the company in a report on Monday, July 27th. Oppenheimer lowered their price objective on HCA Healthcare from $520.00 to $485.00 and set an “outperform” rating for the company in a research report on Monday, July 27th. Weiss Ratings cut shares of HCA Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a report on Tuesday, June 9th. Finally, Leerink Partners lowered their price target on shares of HCA Healthcare from $573.00 to $500.00 and set an “outperform” rating for the company in a report on Monday, April 27th. Fourteen research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $462.64.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.